RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $13

Ardent Health, Inc. +4.98%

Ardent Health, Inc.

ARDT

9.91

+4.98%

RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE: ARDT) with a Outperform and lowers the price target from $14 to $13.